| Treatment of vitamin D deficiency in cystic fibrosis S Chesdachai, V Tangpricha The Journal of steroid biochemistry and molecular biology 164, 36-39, 2016 | 108 | 2016 |
| Associations of proton-pump inhibitors and H2 receptor antagonists with chronic kidney disease: a meta-analysis K Wijarnpreecha, C Thongprayoon, S Chesdachai, P Panjawatanana, ... Digestive diseases and sciences 62, 2821-2827, 2017 | 81 | 2017 |
| Hepatitis C virus infection and risk of Parkinson’s disease: a systematic review and meta-analysis K Wijarnpreecha, S Chesdachai, V Jaruvongvanich, P Ungprasert European journal of gastroenterology & hepatology 30 (1), 9-13, 2018 | 61 | 2018 |
| Vitamin D status is associated with hepcidin and hemoglobin concentrations in children with inflammatory bowel disease S Syed, ES Michalski, V Tangpricha, S Chesdachai, A Kumar, J Prince, ... Inflammatory bowel diseases 23 (9), 1650-1658, 2017 | 60 | 2017 |
| Vitamin D for the Immune System in Cystic Fibrosis (DISC): a double-blind, multicenter, randomized, placebo-controlled clinical trial V Tangpricha, J Lukemire, Y Chen, JNG Binongo, SE Judd, ES Michalski, ... The American Journal of Clinical Nutrition 109 (3), 544-553, 2019 | 42 | 2019 |
| Obesity and the risk of colonic diverticulosis: a meta-analysis K Wijarnpreecha, W Ahuja, S Chesdachai, C Thongprayoon, ... Diseases of the Colon & Rectum 61 (4), 476-483, 2018 | 41 | 2018 |
| The Characteristics of Capnocytophaga Infection: 10 Years of Experience S Chesdachai, DBG Tai, ZA Yetmar, A Misra, N Ough, O Abu Saleh Open Forum Infectious Diseases 8 (7), ofab175, 2021 | 40 | 2021 |
| Outcomes of COVID-19 with the Mayo Clinic model of care and research JC O’Horo, JR Cerhan, EJ Cahn, PR Bauer, Z Temesgen, J Ebbert, ... Mayo Clinic Proceedings 96 (3), 601-618, 2021 | 39 | 2021 |
| The effect of infectious diseases consultation on mortality in hospitalized patients with methicillin-resistant Staphylococcus aureus, Candida, and Pseudomonas bloodstream … S Chesdachai, S Kline, D Helmin, R Rajasingham Open forum infectious diseases 7 (1), ofaa010, 2020 | 33 | 2020 |
| The effects of first-line anti-tuberculosis drugs on the actions of vitamin D in human macrophages S Chesdachai, SM Zughaier, L Hao, RR Kempker, HM Blumberg, ... Journal of clinical & translational endocrinology 6, 23-29, 2016 | 32 | 2016 |
| Minimum Inhibitory Concentration Distribution of Fluconazole Against Cryptococcus Species and the Fluconazole Exposure Prediction Model S Chesdachai, R Rajasingham, MR Nicol, DB Meya, F Bongomin, ... Open forum infectious diseases 6 (10), ofz369, 2019 | 28 | 2019 |
| The Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC) trial: Rationale and design of a multi-center, double-blind, placebo-controlled trial of high dose bolus … V Tangpricha, EM Smith, J Binongo, SE Judd, TR Ziegler, S Walker, ... Contemporary clinical trials communications 6, 39-45, 2017 | 22 | 2017 |
| Risk of cardiovascular implantable electronic device infection in patients presenting with gram-negative bacteremia S Chesdachai, LM Baddour, MR Sohail, BR Palraj, M Madhavan, ... Open forum infectious diseases 9 (9), ofac444, 2022 | 21 | 2022 |
| Evaluation of European Heart Rhythm Association consensus in patients with cardiovascular implantable electronic devices and Staphylococcus aureus bacteremia S Chesdachai, LM Baddour, MR Sohail, BR Palraj, M Madhavan, ... Heart Rhythm 19 (4), 570-577, 2022 | 21 | 2022 |
| Utility of metagenomic next-generation sequencing in infective endocarditis: a systematic review SF Haddad, DC DeSimone, S Chesdachai, DJ Gerberi, LM Baddour Antibiotics 11 (12), 1798, 2022 | 20 | 2022 |
| Mortality after nocardiosis: risk factors and evaluation of disseminated infection ZA Yetmar, RB Khodadadi, S Chesdachai, JW McHugh, DW Challener, ... Open Forum Infectious Diseases 10 (8), ofad409, 2023 | 18 | 2023 |
| Prior statin use and risk of mortality and severe disease from coronavirus disease 2019: a systematic review and meta-analysis ZA Yetmar, S Chesdachai, T Kashour, M Riaz, DJ Gerberi, AD Badley, ... Open Forum Infectious Diseases 8 (7), ofab284, 2021 | 18 | 2021 |
| Efficacy and safety of direct-acting antivirals in hepatitis C virus-infected patients taking proton pump inhibitors K Wijarnpreecha, S Chesdachai, C Thongprayoon, V Jaruvongvanich, ... Journal of Clinical and Translational Hepatology 5 (4), 327, 2017 | 18 | 2017 |
| Epidemiology of parvovirus B19 and anemia among kidney transplant recipients: a meta-analysis C Thongprayoon, NJ Khoury, T Bathini, NR Aeddula, B Boonpheng, ... Urology Annals 12 (3), 241-247, 2020 | 17 | 2020 |
| Prospective, Randomized, Double‐Blind, Parallel‐Group, Comparative Effectiveness Clinical Trial Comparing a Powder Vehicle Compound of Vitamin D With an Oil Vehicle Compound in … WA Hermes, JA Alvarez, MJ Lee, S Chesdachai, D Lodin, R Horst, ... Journal of Parenteral and Enteral Nutrition 41 (6), 952-958, 2017 | 16 | 2017 |
Zachary YetmarCleveland ClinicEmail yang diverifikasi di ccf.org